BioRap Technologies Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:BioRap Technologies Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014077
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioRap Technologies Ltd (BioRap) is a technology transfer company that offers biomedical solutions for contemporary health care industry. The company’s technologies are used in the treatment of macular disease, alopecia, cardiovascular disease, cancer and autoimmune diseases, cancer therapy, blood coagulation, multiple sclerosis, inflammatory bowel disease, prostate cancer, chronic colitis and colitis-associated cancer, and diabetes. Its technologies are used in the therapeutic areas of oncology, neurology, cardiology, hematology, and dermatology. BioRap has collaboration with HaptoGuard Inc, BioLineRx and others. The company caters its therapeutic vaccines, and bio research tools to industries such as biopharmaceutical, medical devices, and medical diagnostics. BioRap is headquartered in Haifa, Israel.

BioRap Technologies Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioRap Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
BioRap Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 9
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BioRap Technologies Enters into Co- Development Agreement with Pfizer 11
Fairjourney Biologics Enters Into Research Agreement With BioRap And Hadasit Medical To Develop Antibodies 12
BioRap Enters into Agreement with GlaxoSmithKline 13
BioRap Technologies Enters into Co-Development Agreement with GlaxoSmithKline 14
Licensing Agreements 15
BioRap Enters into Licensing Agreement with Radikal Therapeutics for CCR5 Soluble Receptor 15
BioRap Technologies Ltd – Key Competitors 16
BioRap Technologies Ltd – Key Employees 17
BioRap Technologies Ltd – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Key Facts 2
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioRap Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioRap Technologies Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
BioRap Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 9
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
BioRap Technologies Enters into Co- Development Agreement with Pfizer 11
Fairjourney Biologics Enters Into Research Agreement With BioRap And Hadasit Medical To Develop Antibodies 12
BioRap Enters into Agreement with GlaxoSmithKline 13
BioRap Technologies Enters into Co-Development Agreement with GlaxoSmithKline 14
BioRap Enters into Licensing Agreement with Radikal Therapeutics for CCR5 Soluble Receptor 15
BioRap Technologies Ltd, Key Competitors 16
BioRap Technologies Ltd, Key Employees 17

★海外企業調査レポート[BioRap Technologies Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Xtant Medical Holdings Inc (XTNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • Meritor, Inc.:企業の戦略・SWOT・財務分析
    Meritor, Inc. - Strategy, SWOT and Corporate Finance Report Summary Meritor, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Schott AG:企業の戦略的SWOT分析
    Schott AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • LegoChem Biosciences Inc (141080):企業の財務・戦略的SWOT分析
    Summary LegoChem Biosciences Inc (LCB) is a bio pharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of anti …
  • JSC Inter RAO:企業のM&A・事業提携・投資動向
    JSC Inter RAO - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JSC Inter RAO Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • UnitedHealth Group Inc (UNH):企業の財務・戦略的SWOT分析
    UnitedHealth Group Inc (UNH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Kunlun Energy Co Ltd (135):企業の財務・戦略的SWOT分析
    Kunlun Energy Co Ltd (135) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Adams Rite Aerospace, Inc.:企業の戦略・SWOT・財務情報
    Adams Rite Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report Summary Adams Rite Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Eickhoff Corporation:企業の戦略・SWOT・財務情報
    Eickhoff Corporation - Strategy, SWOT and Corporate Finance Report Summary Eickhoff Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Korea South-East Power Co Ltd:企業の戦略的SWOT分析
    Korea South-East Power Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Page Industries Ltd:企業の戦略・SWOT・財務分析
    Page Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Page Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Zoo Digital Group plc (ZOO):企業の財務・戦略的SWOT分析
    Summary Zoo Digital Group Plc (ZOO) is a technology company that offers localization and media production services. The company offers services such as subtitling, captioning, dubbing and digital distribution. Its activities include providing a range of services to allow television and movie content …
  • Putzmeister Holding GmbH:企業の戦略・SWOT・財務情報
    Putzmeister Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Putzmeister Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Boardwalk Pipeline Partners LP:企業の戦略・SWOT・財務分析
    Boardwalk Pipeline Partners LP - Strategy, SWOT and Corporate Finance Report Summary Boardwalk Pipeline Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Calimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Calimmune Inc (Calimmune), a subsidiary of CSL Behring Australia Pty Ltd, is a novel gene therapy program developer. The company’s ex vivio autulogus cell therapy includes CAL-1 and CAL-H. Its CAL-1 offers cell therapies for HIV AIDS. Calimmune’s CAL-H cell therapy provides himoglobinopathie …
  • Gear Energy Ltd (GXE):石油・ガス:M&Aディール及び事業提携情報
    Summary Gear Energy Ltd (Gear Energy) is an oil and gas company. The company offers services such as exploration, acquisition, development, operations, management, production and development of low risk, low cost, heavy, and light oil and gas resources. It holds interests, owns and operates petroleu …
  • IPCA Laboratories Ltd (IPCALAB):企業の財務・戦略的SWOT分析
    Summary IPCA Laboratories Ltd (IPCA) is a pharmaceutical company which manufactures and markets active pharmaceutical ingredients, generics and formulations for various therapeutic areas. The company’s active pharmaceutical ingredients include anti-hypertensive, anti-malarial, diuretic and anthelmin …
  • GSS Infotech Limited (GSS):企業の財務・戦略的SWOT分析
    GSS Infotech Limited (GSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Pakistan Oxygen Limited (LINDE):企業の財務・戦略的SWOT分析
    Pakistan Oxygen Limited (LINDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Ionis Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆